06/01/2026
NEWS: "New Cancer injection eliminated tumors in some patients"
Let's analyze one of these typical news stories about a promising mainstream Oncology treatment, or a new Cancer Drug 😂
Amivantamab, a targeted therapy made by Johnson & Johnson is already used for lung cancer.
Amivantamab costs between $250,000 and $330,000 per year.
Is it curative? Of course not! (Don't be silly)
If you believe the Big Pharma Clinical Trials (like the MARIPOSA trial), this $300k drug will give you a few months extra before your cancer comes back and will give you a few months extra overall survival.
Then there are the side effects, of course. 🤷♂️
Could Iv**mectin, Mebenda**le, Fenbenda**le or combinations thereof be far superior to this $300k drug? Absolutely.
But imagine $3000/year worth of Iv**mectin & Mebenda**le vs $300,000 worth of Amivantamab.
Some people make the argument that if Iv**mectin worked better for cancer, all Oncologists would use it.
Yes, humans, especially in highly competitive corporate environments, routinely take 99% salary and profit cuts for the sake of the greater good.
(Hint: they don't).
That's why we need Iv**mectin Clinical Trials in Florida 😉
I have helped over 9000 Cancer patients with Iv**mectin, Mebendazole and Fenbenda**le in the largest Iv**mectin Cancer Project in the world.
Stay tuned for real news...